Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.105 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19254.5Singapore
B.1.145ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-19249.8China
AY.123 (Delta)NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19239.7China
AY.82 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19217.1Germany
B.1.177.61NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19217.1Germany
B.1.599NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19217.1Germany
KB.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19217.1Germany
BA.4.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.6.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
AY.88 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BF.7.16NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.6.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.6.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.6.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BE.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
BA.4.1.10NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
CS.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19212.8Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used